DrMHB

@drmhb.bsky.social

Faculty at Harvard School of Medicine Assistant Professor, Multiple Myeloma clinician and clinical researcher @ Dana-Farber Cancer Institute

Me, a public health person, just sitting over here reflecting on the fact that the US has experienced a 7% increase in infant mortality post-Dobbs. Like, do you realize what that says about this society from an ethical perspective? That we made policy choices that caused this? #PHEthx

Infant Mortality Increases Across US Following Dobbs Decision

The Dobbs decision was associated with a 7% absolute increase in overall infant mortality—equivalent to 247 excess deaths—and a 10% increase among infants with congenital anomalies, corresponding to 2...

ajmc.com

The quintessential ASH pic. Great meeting, lots of advancements in myeloma management, MRD negative sustainability see you soon…😉Our MM patients, we hear you! 😘

Bild

Pfizer's sudden withdrawal of Oxbryta, a drug for #SickleCell disease, "shocked patients and providers alike, risking reigniting mistrust in a health care system that has long overlooked the needs of the Black community." www.statnews.com/2024/12/08/a... #HemeSky

Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference

Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf”

statnews.com